NSE BSE
sun pharmaceutical ind l stock

SUN PHARMACEUTICAL IND L Share Price

- - (%)
- NSE: SUNPHARMA

SUN PHARMACEUTICAL IND L Share Price Update

As of the latest trading session, SUN PHARMACEUTICAL IND L share price is currently at 1568.65, which is down by -25.59 from its previous closing. Today, the stock has fluctuated between 1565.15 and 1589.75. Over the past year, SUN PHARMACEUTICAL IND L has achieved a return of 44.99 %. In the last month alone, the return has been 4.29 %. Read More...

SUN PHARMACEUTICAL IND L Performance

Day Range

Low1565.15 High1589.75
1568.65

52 Week Range

Low 1068.35 High 1638.85
1568.65

SUN PHARMACEUTICAL IND L Share Price

3351

524715

SUNPHARMA

img img img img
No Data Available

Open Price

1584.70

Prev. Close

1594.25

Volume (Shares)

1649335.00

Total traded value

25872.29

Upper Circuit

1753.65

Lower Circuit

1434.85

Note: The current prices & values are delayed, Login to your account for live updates.

SUN PHARMACEUTICAL IND L Fundamentals


(Standalone)

Market Cap (Cr) 376371.70
PE Ratio (TTM) 131.69
Book Value / Share 98.75
Beta 0.45
ROE 12.05%
EPS (TTM) 12.72
Dividend Yield 0.86%
Net Profit Qtr (Cr) 867.60

SUN PHARMACEUTICAL IND L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 5536.99
Operating Expense 4356.24
Net Profit 867.60
Net Profit Margin (%) 15.66
Earnings Per Share (EPS) 3.60
EBITDA 2012.40
Effective Tax Rate (%) 38.10
Particulars DEC 2023 (Values in Cr)
Revenue 4903.66
Operating Expense 4329.27
Net Profit 721.31
Net Profit Margin (%) 14.70
Earnings Per Share (EPS) 3.00
EBITDA 1365.99
Effective Tax Rate (%) 4.01
Particulars SEP 2023 (Values in Cr)
Revenue 5019.54
Operating Expense 4296.23
Net Profit 888.63
Net Profit Margin (%) 17.70
Earnings Per Share (EPS) 3.70
EBITDA 1492.86
Effective Tax Rate (%) 1.97
Particulars JUN 2023 (Values in Cr)
Revenue 4383.34
Operating Expense 4090.52
Net Profit 380.64
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 1.60
EBITDA 963.08
Effective Tax Rate (%) 2.36
Particulars MAR 2023 (Values in Cr)
Revenue 5800.85
Operating Expense 4161.00
Net Profit -1020.82
Net Profit Margin (%) -17.59
Earnings Per Share (EPS) -4.30
EBITDA -456.83
Effective Tax Rate (%) 0.91
Particulars MAR 2024 (Values in Cr)
Revenue 19843.53
Operating Expense 17072.26
Net Profit 2858.18
Net Profit Margin (%) 14.40
Earnings Per Share (EPS) 11.90
EBITDA 5834.35
Effective Tax Rate (%) 17.14
Particulars MAR 2023 (Values in Cr)
Revenue 20394.63
Operating Expense 16412.32
Net Profit 1690.72
Net Profit Margin (%) 8.29
Earnings Per Share (EPS) 7.00
EBITDA 3814.10
Effective Tax Rate (%) 2.89
Particulars MAR 2022 (Values in Cr)
Revenue 15518.50
Operating Expense 14416.51
Net Profit -99.99
Net Profit Margin (%) -0.64
Earnings Per Share (EPS) -0.40
EBITDA 2044.91
Effective Tax Rate (%) 132.58
Particulars MAR 2021 (Values in Cr)
Revenue 13988.40
Operating Expense 13362.99
Net Profit 842.40
Net Profit Margin (%) 6.02
Earnings Per Share (EPS) 3.50
EBITDA 2359.52
Effective Tax Rate (%) 1.53
Particulars MAR 2020 (Values in Cr)
Revenue 11906.74
Operating Expense 10789.85
Net Profit 3211.14
Net Profit Margin (%) 26.96
Earnings Per Share (EPS) 13.38
EBITDA 4222.57
Effective Tax Rate (%) 1.28
Particulars MAR 2024 (Values in Cr)
Book Value / Share 265.36
ROE % 16.13
ROCE % 17.20
Total Debt to Total Equity 0.08
EBITDA Margin 28.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 233.38
ROE % 16.46
ROCE % 16.79
Total Debt to Total Equity 0.08
EBITDA Margin 27.59
Particulars MAR 2022 (Values in Cr)
Book Value / Share 200.11
ROE % 14.50
ROCE % 17.97
Total Debt to Total Equity 0.05
EBITDA Margin 29.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 193.65
ROE % 11.14
ROCE % 13.60
Total Debt to Total Equity 0.13
EBITDA Margin 27.80
Particulars MAR 2020 (Values in Cr)
Book Value / Share 188.66
ROE % 9.66
ROCE % 9.85
Total Debt to Total Equity 0.22
EBITDA Margin 22.43
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5770.29
Total Assets 80743.59
Total Liabilities 80743.59
Total Equity 59315.47
Share Outstanding 2399334970
Price to Book Ratio 9.93
Return on Assets (%) 10.49
Return on Capital (%) 12.93
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5033.35
Total Assets 69807.77
Total Liabilities 69807.77
Total Equity 51066.11
Share Outstanding 2399334970
Price to Book Ratio 8.93
Return on Assets (%) 4.68
Return on Capital (%) 6.29
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6445.51
Total Assets 67666.73
Total Liabilities 67666.73
Total Equity 49479.83
Share Outstanding 2399334970
Price to Book Ratio 5.32
Return on Assets (%) 4.29
Return on Capital (%) 5.48
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6487.55
Total Assets 68252.46
Total Liabilities 68252.46
Total Equity 49124.69
Share Outstanding 2399334970
Price to Book Ratio 3.46
Return on Assets (%) 5.51
Return on Capital (%) 6.64
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 7275.60
Total Assets 64693.81
Total Liabilities 64693.81
Total Equity 44722.60
Share Outstanding 2399334970
Price to Book Ratio 5.03
Return on Assets (%) 4.12
Return on Capital (%) 4.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 338.39
Total Assets 41064.79
Total Liabilities 41064.79
Total Equity 23694.40
Share Outstanding 2399334970
Price to Book Ratio 16.41
Return on Assets (%) 6.96
Return on Capital (%) 8.23
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 421.28
Total Assets 40987.49
Total Liabilities 40987.49
Total Equity 23748.36
Share Outstanding 2399334970
Price to Book Ratio 9.93
Return on Assets (%) 4.12
Return on Capital (%) 5.39
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 534.96
Total Assets 40765.48
Total Liabilities 40765.48
Total Equity 24587.95
Share Outstanding 2399334970
Price to Book Ratio 8.93
Return on Assets (%) -0.24
Return on Capital (%) -0.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 360.98
Total Assets 43734.79
Total Liabilities 43734.79
Total Equity 26938.47
Share Outstanding 2399334970
Price to Book Ratio 5.32
Return on Assets (%) 1.92
Return on Capital (%) 2.47
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 654.78
Total Assets 38410.33
Total Liabilities 38410.33
Total Equity 24396.22
Share Outstanding 2399334970
Price to Book Ratio 3.46
Return on Assets (%) 8.36
Return on Capital (%) 10.65
Particulars MAR 2024 (Values in Cr)
Net Income 11087.89
Cash from Operations 13704.42
Cash from Investing -690.20
Cash from Financing -6710.16
Net change in Cash 4734.62
Free Cash Flow 15906.23
Particulars MAR 2023 (Values in Cr)
Net Income 9408.43
Cash from Operations 6469.17
Cash from Investing -7943.68
Cash from Financing 2376.07
Net change in Cash -608.28
Free Cash Flow 8554.75
Particulars MAR 2022 (Values in Cr)
Net Income 4481.32
Cash from Operations 8015.32
Cash from Investing -5724.74
Cash from Financing -5193.46
Net change in Cash -1933.66
Free Cash Flow 9510.36
Particulars MAR 2021 (Values in Cr)
Net Income 2799.37
Cash from Operations 7173.31
Cash from Investing 536.22
Cash from Financing -5980.48
Net change in Cash 726.11
Free Cash Flow 8343.44
Particulars MAR 2020 (Values in Cr)
Net Income 5009.59
Cash from Operations 7900.68
Cash from Investing -2588.84
Cash from Financing -5715.14
Net change in Cash -1749.21
Free Cash Flow 9442.68
Particulars MAR 2024 (Values in Cr)
Net Income 3449.65
Cash from Operations 49.45
Cash from Investing -262.91
Cash from Financing 473.95
Net change in Cash -81.38
Free Cash Flow 798.69
Particulars MAR 2023 (Values in Cr)
Net Income 1741.05
Cash from Operations 939.07
Cash from Investing -705.17
Cash from Financing 169.31
Net change in Cash -28.78
Free Cash Flow 1901.50
Particulars MAR 2022 (Values in Cr)
Net Income 306.86
Cash from Operations 5476.82
Cash from Investing -2702.10
Cash from Financing -4870.85
Net change in Cash 63.41
Free Cash Flow 6326.71
Particulars MAR 2021 (Values in Cr)
Net Income 855.57
Cash from Operations -178.84
Cash from Investing 1463.81
Cash from Financing -999.73
Net change in Cash 47.57
Free Cash Flow 629.23
Particulars MAR 2020 (Values in Cr)
Net Income 3253.00
Cash from Operations 1642.90
Cash from Investing 1479.29
Cash from Financing -2871.15
Net change in Cash -86.01
Free Cash Flow 2214.71
Company Name Price P/E P/B Market Cap 52 Week Low/High
SUN PHARMACEUTICAL IND L 1568.45 37.67 5.91 376323.69 1069.00 / 1638.70
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1580.00
  • 26 Days 1548.40
  • 10 Days 1577.60
  • 50 Days 1532.40
  • 12 Days 1571.20
  • 100 Days 1535.30
  • 20 Days 1551.90
  • 200 Days 1188.90
1587.03
PIVOT
First Resistance 1603.82
Second Resistance 1613.38
Third Resistance 1630.17
First Support 1577.47
Second Support 1560.68
Third Support 1551.12
RSI 63.22
MACD 22.72
Commodity Channel Index (CCI) 58.52
ADX 12.97
Williams % R -32.49

Over 1 Month

down

4.29

Over 3 Months

down

3.01

Over 6 Months

down

17.44

Over 1 Year

down

44.99

Over 3 Years

down

31.53

Over 5 Years

down

30.06

SUN PHARMACEUTICAL IND L Future

Future: Price

30 May
1534.65
27 Jun
1545.90
25 Jul
1550.55
25 May
0 100 200 300 400 500 600

Discount/Premium

25 Jul
3.30
29 Aug
12.55
25 May
0 1 2 3 4 5 6 7

Active Calls

1550.0
3177
1540.0
2817
1600.0
1882
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

1520.0
1819
1530.0
1555
1540.0
1306
25 Jul
0 500 1000 1500 2000 2500

SUN PHARMACEUTICAL IND L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
15.51
Promoter Holdings
54.48
FII
17.23
DII
12.78
Promoter Shares(Pledge Percentage)
1.07
Name Category Shares Shares%
Shanghvi Finance Private Limited Shareholding of Promoter and Promoter Group 9.67051732E8 40.3
Dilip S. Shanghvi Shareholding of Promoter and Promoter Group 2.30385155E8 9.6
Icici Prudential Value Discovery Fund Public Shareholding 9.7529931E7 4.06
Life Insurance Corporation Of India Public Shareholding 7.4399715E7 3.1
Sbi Nifty 50 Etf Public Shareholding 5.035978E7 2.1
Aditya Medisales Limited Shareholding of Promoter and Promoter Group 4.015396E7 1.67
Raksha S.valia Shareholding of Promoter and Promoter Group 2.8830352E7 1.2
Nps Trust- A/c Hdfc Pension Management Company Ltd Scheme E - Tier I Public Shareholding 2.8462519E7 1.19
Lakshdeep Investments & Finance (p) Ltd. Public Shareholding 2.4418497E7 1.02
Hdfc Trustee Company Ltd. A/c Hdfc Balanced Advantage Fund Public Shareholding 2.4323189E7 1.01
Sudhir V. Valia Shareholding of Promoter and Promoter Group 1.4345019E7 0.6
Unimed Investments Limited Shareholding of Promoter and Promoter Group 1.040085E7 0.43
Vibha Dilip Shanghvi Shareholding of Promoter and Promoter Group 8840280.0 0.37
Vidhi Dilip Shanghvi Shareholding of Promoter and Promoter Group 2822427.0 0.12
Aalok Dilip Shanghvi Shareholding of Promoter and Promoter Group 2877280.0 0.12
Shanghvi Family & Friends Benefit Trust Shareholding of Promoter and Promoter Group 1276774.0 0.05
Gujarat Sun Pharmaceutical Industries Pvt Ltd Shareholding of Promoter and Promoter Group 14362.0 0.0
Sanghvi Properties Private Limited Shareholding of Promoter and Promoter Group 15479.0 0.0
Flamboyawer Finance Private Limited Shareholding of Promoter and Promoter Group 20865.0 0.0
Kumud Shantilal Shanghvi Shareholding of Promoter and Promoter Group 100000.0 0.0

SUN PHARMACEUTICAL IND L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-09 8.5 Interim 2024-02-09 Equity shares 2023-07-28 4.0 Final 2023-07-28 Equity shares 2023-02-08 7.5 Interim 2023-02-08 Equity shares 2022-08-19 3.0 Final 2022-08-22 Equity shares 2022-02-09 7.0 Interim 2022-02-10 Equity shares 2021-08-23 2.0 Final 2021-08-25 Equity shares 2021-02-09 5.5 Interim 2021-02-10 Equity shares 2020-08-19 1.0 Final 2020-08-21 Equity shares 2020-02-17 3.0 Interim 2020-02-18 Equity shares 2019-08-20 2.75 Final 2019-08-22 Equity shares 2018-09-17 2.0 Final 2018-09-19 Equity shares 2017-09-18 3.5 Final 2017-09-20 Equity shares 2016-09-08 1.0 Final 2016-09-10 Equity shares 2015-10-21 3.0 Final 2015-10-24 Equity shares 2014-09-11 1.5 Final 2014-09-13 Equity shares 2013-09-19 2.5 Final 2013-09-23 Equity shares 2012-08-14 4.25 Interim 2012-08-16 Equity shares 2011-09-02 3.5 Final 2011-09-06 Equity shares 2010-09-09 13.75 Final 2010-09-14 Equity shares 2009-08-21 13.75 Final 2009-08-25 Equity shares 2008-08-25 10.5 Final 2008-08-27 Equity shares 2007-03-15 6.75 Final 2007-03-16 Equity shares 2005-09-19 0.0 Final 2005-09-21 Equity shares
Ex-Date Ex-Bonus Ratio
2013-07-30 2013-07-29 1:1 2004-05-29 2004-05-27 1:1 2000-03-23 2000-03-06 2:1
Ex-Date Old FV NEW FV Record Date
2010-11-25 5.0 1.0 2010-11-26 2003-01-13 10.0 5.0 2003-01-21

Sun Pharmaceutical Industries Ltd Overview

Sun Pharmaceutical Industries Ltd, headquartered in India, is a global frontrunner in the pharmaceutical sector, holding the title of the largest pharmaceutical company in India. Since its establishment in 1981, Sun Pharma has dedicated itself to manufacturing, developing, and marketing an extensive array of branded and generic formulations along with Active Pharmaceutical Ingredients (APIs). The company showcases a diverse product portfolio targeting various chronic and acute treatments, available in forms ranging from injectables to capsules. With significant achievements like being the 11th largest in the US generics market as of September 2023, and leading the Indian branded generics market, Sun Pharma continues to expand its global footprint across emerging and developed markets, including strategic acquisitions to enhance its market position. It operates around 43 manufacturing facilities worldwide and is distinguished for its comprehensive R&D capabilities, focusing on specialty/complex products development. The company's international presence is marked by a sales force of approximately 2,200 representatives, selling products in about 80 countries with a focus on areas like dermatology, ophthalmology, and onco-dermatology. Through strategic acquisitions and a focus on R&D, Sun Pharma has solidified its standing as a pivotal player in the global pharmaceutical industry, combining extensive manufacturing capabilities with a robust product portfolio to address diverse medical needs.

Learn More About Stocks

About SUN PHARMACEUTICAL IND L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SUN PHARMACEUTICAL IND L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sun Pharmaceuticals Industries Ltd?

Answer Field

The share price of Sun Pharmaceuticals Industries Ltd for NSE is ₹ 1568.65 and for BSE is ₹ 1566.7.

What is the Market Cap of Sun Pharmaceuticals Industries Ltd?

Answer Field

The market cap of Sun Pharmaceuticals Industries Ltd for NSE is ₹ 37,63,71.70 Cr. and for BSE is ₹ 37,59,03.80 Cr. as of now.

What is the 52 Week High and Low of Sun Pharmaceuticals Industries Ltd?

Answer Field

The 52 Week High and Low of Sun Pharmaceuticals Industries Ltd for NSE is ₹ 1638.85 and ₹ 1068.35 and for BSE is ₹ 1638.70 and ₹ 1069.00.

How to Buy Sun Pharmaceuticals Industries Ltd share?

Answer Field

You can trade in Sun Pharmaceuticals Industries Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sun Pharmaceuticals Industries Ltd?

Answer Field

The 1 year returns on the stock has been 44.99%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader